Dr. Athiya Agarwal has submitted to the Exchange a copy of Disclosures under Regulation 10(6)-Report to stock Exchange in respect of any acquisition made in reliance upon exemption provided for in regulation 10 of SEBI (SAST) Regulations, 2011.
AGARWALEYE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Athiya Agarwal received 14,85,822 shares (0.47% of diluted share capital) of Dr. Agarwal's Health Care Limited from her son Dr. Anosh Agarwal on 24 February 2026 by way of gift — no cash consideration involved. Both are part of the promoter and promoter group, and the transfer qualifies as an inter-se transfer between immediate relatives under SEBI Takeover Regulations, exempting it from an open offer. Post-transaction, Dr. Athiya Agarwal's holding rose from 2.86% to 3.33%, while Dr. Anosh Agarwal's holding dropped from 5.83% to 5.36%. The total promoter and promoter group shareholding remains unchanged since this is just a reshuffle within the family.
This is a routine internal family reshuffle with no change in total promoter ownership, so there is no material impact on the stock price or minority shareholders. The transfer was done as a gift at no consideration, and all SEBI disclosure timelines were followed.